X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (50430) 50430
Book Review (8436) 8436
Publication (5266) 5266
Newsletter (2452) 2452
Book Chapter (330) 330
Newspaper Article (325) 325
Conference Proceeding (119) 119
Transcript (96) 96
Dissertation (80) 80
Book / eBook (35) 35
Magazine Article (31) 31
Reference (16) 16
Data Set (9) 9
Trade Publication Article (8) 8
Web Resource (5) 5
Paper (3) 3
Streaming Video (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (42724) 42724
humans (32772) 32772
animals (18503) 18503
b cells (13997) 13997
immunology (13295) 13295
mice (12614) 12614
female (11935) 11935
male (10845) 10845
oncology (10647) 10647
hematology (8288) 8288
b-cells (7885) 7885
cancer (7362) 7362
middle aged (7162) 7162
expression (6803) 6803
research (6702) 6702
adult (6301) 6301
aged (5959) 5959
apoptosis (5794) 5794
b-lymphocytes - immunology (5767) 5767
analysis (5520) 5520
lymphomas (5482) 5482
cell line (5411) 5411
proteins (5303) 5303
cell biology (5069) 5069
gene expression (5063) 5063
lymphocytes (5017) 5017
cell line, tumor (4733) 4733
b-cell lymphoma (4613) 4613
health aspects (4563) 4563
t cells (4504) 4504
lymphocytes b (4354) 4354
lymphoma (4199) 4199
biochemistry & molecular biology (4192) 4192
activation (4145) 4145
research article (4045) 4045
multidisciplinary sciences (4008) 4008
abridged index medicus (3812) 3812
medicine (3765) 3765
genetic aspects (3749) 3749
flow cytometry (3725) 3725
signal transduction (3697) 3697
antigens (3573) 3573
rituximab (3424) 3424
care and treatment (3368) 3368
leukemia (3232) 3232
prognosis (3232) 3232
article (3203) 3203
antibodies (3070) 3070
molecular sequence data (3067) 3067
b-lymphocytes - metabolism (3066) 3066
chemotherapy (3022) 3022
science (3010) 3010
genes (3005) 3005
mutation (2934) 2934
t-cells (2885) 2885
tumor cells, cultured (2874) 2874
dendritic cells (2809) 2809
cells, cultured (2780) 2780
aged, 80 and over (2778) 2778
medicine, research & experimental (2734) 2734
immunoglobulins (2726) 2726
biology (2700) 2700
mice, inbred c57bl (2673) 2673
physiological aspects (2673) 2673
cytokines (2647) 2647
non-hodgkins-lymphoma (2572) 2572
survival (2563) 2563
b-cell (2521) 2521
hemic and lymphatic diseases (2495) 2495
medical research (2458) 2458
inflammation (2417) 2417
immunotherapy (2399) 2399
base sequence (2389) 2389
tumors (2379) 2379
treatment outcome (2373) 2373
pathology (2372) 2372
t-lymphocytes - immunology (2357) 2357
disease (2311) 2311
chronic lymphocytic-leukemia (2299) 2299
in-vivo (2295) 2295
mice, inbred balb c (2287) 2287
differentiation (2220) 2220
rodents (2181) 2181
cell proliferation (2170) 2170
immune system (2154) 2154
phosphorylation (2146) 2146
immune response (2091) 2091
autoimmunity (2078) 2078
development and progression (2062) 2062
therapy (2050) 2050
antineoplastic combined chemotherapy protocols - therapeutic use (2048) 2048
lymphocytes t (2048) 2048
gene-expression (2037) 2037
adolescent (2009) 2009
kinases (2006) 2006
amino acid sequence (1990) 1990
chronic lymphocytic leukemia (1986) 1986
medicine & public health (1920) 1920
cells (1919) 1919
gene (1916) 1916
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (52091) 52091
Chinese (1044) 1044
Japanese (153) 153
German (104) 104
French (54) 54
Russian (42) 42
Spanish (34) 34
Danish (30) 30
Korean (22) 22
Swedish (18) 18
Polish (11) 11
Czech (8) 8
Hungarian (7) 7
Italian (5) 5
Persian (2) 2
Portuguese (2) 2
Dutch (1) 1
Norwegian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Immunology, ISSN 0019-2805, 12/2017, Volume 152, Issue 4, pp. 562 - 573
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 7, pp. 928 - 942
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9873, pp. 1203 - 1210
Summary Background Rituximab plus chemotherapy, most often CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone), is the first-line standard of... 
Internal Medicine | SURVIVAL | MAINTENANCE | MEDICINE, GENERAL & INTERNAL | II MULTICENTER | B-CELL | ADVANCED FOLLICULAR LYMPHOMA | CYCLOPHOSPHAMIDE | VINCRISTINE | NON-HODGKINS-LYMPHOMA | COMBINATION | CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prospective Studies | Nitrogen Mustard Compounds - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cyclophosphamide - adverse effects | Vincristine - administration & dosage | Adult | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Prednisone - adverse effects | Lymphoma, Mantle-Cell - drug therapy | Rituximab | Treatment Outcome | Nitrogen Mustard Compounds - adverse effects | Disease-Free Survival | Bendamustine Hydrochloride | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - adverse effects | Aged | Infusions, Intravenous | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Usage | Chemotherapy | Bendamustine | Patient outcomes | Lymphomas | Research | Drug therapy | Comparative analysis | Cancer | Antimitotic agents | Care and treatment | Antineoplastic agents | Analysis | Bone marrow | Hematology | Index Medicus | Abridged Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2012, Volume 7, Issue 6, pp. e39945 - e39945
Background: A number of constitutively activated signaling pathways play critical roles in the survival and growth of primary effusion lymphoma cells (PELs)... 
KAPPA-B ACTIVATION | INHIBITION | CONSTITUTIVE ACTIVATION | SARCOMA-ASSOCIATED HERPESVIRUS | KINASE PROTEIN-2 DEGRADATION | BIOLOGY | BAX | FATTY-ACID SYNTHASE | MITOCHONDRIAL-MEMBRANE | CANCER | EXPRESSION | Nitriles - pharmacology | Apoptosis - drug effects | Humans | Lymphoma, Primary Effusion - enzymology | NF-kappa B - metabolism | Phosphatidylinositol 3-Kinases - metabolism | I-kappa B Proteins - metabolism | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Sulfones - pharmacology | Caspases - metabolism | Phosphorylation - drug effects | Proto-Oncogene Proteins c-akt - metabolism | Cell Survival - drug effects | NF-KappaB Inhibitor alpha | NF-kappa B - antagonists & inhibitors | Lymphoma, Primary Effusion - pathology | Mitochondria - metabolism | Mitochondria - drug effects | Down-Regulation - drug effects | Enzyme Activation - drug effects | Apoptosis Regulatory Proteins - metabolism | Drug Synergism | Signal Transduction - drug effects | Cell Line, Tumor | Cell Proliferation - drug effects | Protein Kinase Inhibitors - pharmacology | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Genetic engineering | Lymphomas | RNA | Multiple myeloma | Apoptosis | Cytochrome | Phosphorylation | Colorectal cancer | AKT protein | Kinases | Drug resistance | Cancer therapies | Proteins | Pathways | Cascades | Cell cycle | Inhibition | Primary effusion lymphoma | Drug dosages | NF-κB protein | Enzymes | Cell survival | Hematology | Effusion | RNA-mediated interference | Pharmacology | siRNA | Tumor cell lines | Ribonucleic acid--RNA | Survival | Lymphoma | 1-Phosphatidylinositol 3-kinase | Gene silencing | Signaling | Lymphocytes B | Cell lines | Viability | B-cell lymphoma | Index Medicus | Ribonucleic acid
Journal Article
Blood, ISSN 0006-4971, 07/2016, Volume 128, Issue 2, pp. 195 - 203
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2015, Volume 10, Issue 11, pp. e0139663 - e0139663
Primary mediastinal B-Cell lymphoma (PMBL) is a recently defined entity comprising similar to 2-10% non-Hodgkin lymphomas (NHL). Unlike most NHL subtypes, PMBL... 
REED-STERNBERG CELLS | IN-VITRO | ACTIVATION | FREQUENT | PROTEIN | MULTIDISCIPLINARY SCIENCES | GRAY ZONE LYMPHOMA | TUMOR-SUPPRESSOR GENE | CLASSICAL HODGKIN LYMPHOMA | MUTATIONS | NF-KAPPA-B | Mediastinal Neoplasms - genetics | Humans | Gene Expression Regulation, Neoplastic | In Situ Hybridization, Fluorescence | DNA Copy Number Variations - genetics | Gene Expression Profiling | Genetic Loci | Lymphoma, B-Cell - genetics | Loss of Heterozygosity - genetics | Comparative Genomic Hybridization | Cell Line, Tumor | Polymorphism, Single Nucleotide - genetics | Female | Spectral Karyotyping | Transcription, Genetic | Aged | Cytogenetic Analysis | Genome, Human | Principal Component Analysis | Cluster Analysis | Care and treatment | Chemotherapy | Analysis | Genetic aspects | Non-Hodgkin's lymphomas | Research | Gene expression | Health aspects | Risk factors | Cancer | Cell culture | Biotechnology | Profiling | Transcription | Genes | Genomes | Single-nucleotide polymorphism | Inactivation | Cancer therapies | MSH6 protein | Microorganisms | Janus kinase 2 | DNA methylation | Bioindicators | Lesions | Deoxyribonucleic acid--DNA | Deactivation | Hematology | Complications | Cloning | Chromosome 6 | Artificial chromosomes | Tumor cell lines | Lymphoma | Loci | Chromosome 2 | CIITA protein | Gene silencing | Chromosome translocations | DNA microarrays | Lymphocytes B | Biomarkers | Cytogenetics | Lymphomas | Mutation | B-cell lymphoma | Index Medicus | Deoxyribonucleic acid | DNA
Journal Article